Methamphetamine-sensitized mice are accompanied by memory impairment and reduction of N-methyl-d-aspartate receptor ligand binding in the prefrontal cortex and hippocampus

Neuroscience

Volumn 178, Issue , 2011, Pages 101-107

  Lee, K W ^a   Kim, H C ^b   Lee, S Y ^a   Jang, C G ^a  

^a Sungkyunkwan University   (South Korea)

^b Kangwon National University   (South Korea)

Author keywords

Behavioral sensitization; Hippocampus; Memory; Methamphetamine; NMDA receptor; Prefrontal cortex

Indexed keywords

METHAMPHETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; HIPPOCAMPUS; LEARNING DISORDER; LIGAND BINDING; LOCOMOTION; MALE; MAZE TEST; MEMORY DISORDER; MOUSE; NONHUMAN; PASSIVE AVOIDANCE; PREFRONTAL CORTEX; PRIORITY JOURNAL; RECEPTOR BINDING; SENSITIZATION; TASK PERFORMANCE; WORKING MEMORY;

ANIMALS; AUTORADIOGRAPHY; AVOIDANCE LEARNING; DIZOCILPINE MALEATE; HIPPOCAMPUS; MALE; MAZE LEARNING; MEMORY; METHAMPHETAMINE; MICE; MICE, INBRED ICR; MOTOR ACTIVITY; PREFRONTAL CORTEX; RADIOLIGAND ASSAY; RECEPTORS, N-METHYL-D-ASPARTATE; TRITIUM;

EID: 79952004421     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.01.025     Document Type: Article

References (52)

1. Asaad W.F., Rainer G., Miller E.K. Neural activity in the primate prefrontal cortex during associative learning. Neuron 1998, 21:1399-1407.
2. Bast T., Zhang W.N., Feldon J. Dorsal hippocampus and classical fear conditioning to tone and context in rats: effects of local NMDA-receptor blockade and stimulation. Hippocampus 2003, 13:657-675.
3. Bisagno V., Ferguson D., Luine V.N. Short toxic methamphetamine schedule impairs object recognition task in male rats. Brain Res 2002, 940:95-101.
4. Bliss T.V., Collingridge G.L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 1993, 361:31-39.
5. Chapman D.E., Hanson G.R., Kesner R.P., Keefe K.A. Long-term changes in basal ganglia function after a neurotoxic regimen of methamphetamine. J Pharmacol Exp Ther 2001, 296:520-527.
6. Cimadevilla J.M., Mendez M., Mendez-Lopez M., Arias J.L. Unilateral hippocampal blockade reveals that one hippocampus is sufficient for learning a passive avoidance task. J Neurosci Res 2007, 85:1138-1142.
7. Conrad C.D., Galea L.A., Kuroda Y., McEwen B.S. Chronic stress impairs rat spatial memory on the Y maze, and this effect is blocked by tianeptine pretreatment. Behav Neurosci 1996, 110:1321-1334.
8. Daberkow D.P., Kesner R.P., Keefe K.A. Relation between methamphetamine-induced monoamine depletions in the striatum and sequential motor learning. Pharmacol Biochem Behav 2005, 81:198-204.
9. DeVito L.M., Lykken C., Kanter B.R., Eichenbaum H. Prefrontal cortex: role in acquisition of overlapping associations and transitive inference. Learn Mem 2010, 17:161-167.
10. Eisch A.J., O'Dell S.J., Marshall J.F. Striatal and cortical NMDA receptors are altered by a neurotoxic regimen of methamphetamine. Synapse 1996, 22:217-225.
11. Friedman S.D., Castaneda E., Hodge G.K. Long-term monoamine depletion, differential recovery, and subtle behavioral impairment following methamphetamine-induced neurotoxicity. Pharmacol Biochem Behav 1998, 61:35-44.
12. Gerber D.J., Sotnikova T.D., Gainetdinov R.R., Huang S.Y., Caron M.G., Tonegawa S. Hyperactivity, elevated dopaminergic transmission, and response to amphetamine in M1 muscarinic acetylcholine receptor-deficient mice. Proc Natl Acad Sci U S A 2001, 98:15312-15317.
13. Goldman-Rakic P.S. Circuitry of the frontal association cortex and its relevance to dementia. Arch Gerontol Geriatr 1987, 6:299-309.
14. Hallett P.J., Standaert D.G. Rationale for and use of NMDA receptor antagonists in Parkinson's disease. Pharmacol Ther 2004, 102:155-174.
15. Hanson G.R., Rau K.S., Fleckenstein A.E. The methamphetamine experience: a NIDA partnership. Neuropharmacology 2004, 47:92-100.
16. Ito Y., Takuma K., Mizoguchi H., Nagai T., Yamada K. A novel azaindolizinone derivative ZSET1446(spiro[imidazo[1,2-a]pyridine-3,2-indan]-2(3H)-one) improves methamphetamine-induced impairment of recognition memory in mice by activating extracellular signal-regulated kinase 1/2. J Pharmacol Exp Ther 2007, 320:819-827.
17. Jang C., Park Y., Rockhold R.W., Ho I.K. Autoradiographic study of NMDA-displaceable [3H]glutamate and [3H]MK-801 binding during butorphanol withdrawal in the rat brain. Brain Res 1999, 845:236-241.
18. Kalechstein A.D., Newton T.F., Green M. Methamphetamine dependence is associated with neurocognitive impairment in the initial phases of abstinence. J Neuropsychiatry Clin Neurosci 2003, 15:215-220.
19. Kalivas P.W., Sorg B.A., Hooks M.S. The pharmacology and neural circuitry of sensitization to psychostimulants. Behav Pharmacol 1993, 4:315-334.
20. Kamei H., Nagai T., Nakano H., Togan Y., Takayanagi M., Takahashi K., Kobayashi K., Yoshida S., Maeda K., Takuma K., Nabeshima T., Yamada K. Repeated methamphetamine treatment impairs recognition memory through a failure of novelty-induced ERK1/2 activation in the prefrontal cortex of mice. Biol Psychiatry 2006, 59:75-84.
21. Karler R., Calder L.D., Turkanis S.A. DNQX blockade of amphetamine behavioral sensitization. Brain Res 1991, 552:295-300.
22. Kim D.H., Hung T.M., Bae K.H., Jung J.W., Lee S., Yoon B.H., Cheong J.H., Ko K.H., Ryu J.H. Gomisin A improves scopolamine-induced memory impairment in mice. Eur J Pharmacol 2006, 542:129-135.
23. Kitanaka J., Kitanaka N., Takemura M. Chronic methamphetamine administration reduces histamine-stimulated phosphoinositide hydrolysis in mouse frontal cortex. Biochem Biophys Res Commun 2003, 300:932-937.
24. Le Greves M., Zhou Q., Berg M., Le Greves P., Fholenhag K., Meyerson B., Nyberg F. Growth hormone replacement in hypophysectomized rats affects spatial performance and hippocampal levels of NMDA receptor subunit and PSD-95 gene transcript levels. Exp Brain Res 2006, 173:267-273.
25. LeDoux J.E. Emotional memory systems in the brain. Behav Brain Res 1993, 58:69-79.
26. Malenka R.C., Nicoll R.A. NMDA-receptor-dependent synaptic plasticity: multiple forms and mechanisms. Trends Neurosci 1993, 16:521-527.
27. Mark K.A., Quinton M.S., Russek S.J., Yamamoto B.K. Dynamic changes in vesicular glutamate transporter 1 function and expression related to methamphetamine-induced glutamate release. J Neurosci 2007, 27:6823-6831.
28. Miller E.K. The prefrontal cortex and cognitive control. Nat Rev Neurosci 2000, 1:59-65.
29. Miyamoto Y., Yamada K., Nagai T., Mori H., Mishina M., Furukawa H., Noda Y., Nabeshima T. Behavioural adaptations to addictive drugs in mice lacking the NMDA receptor epsilon1 subunit. Eur J Neurosci 2004, 19:151-158.
30. Moriguchi S., Watanabe S., Kita H., Nakanishi H. Enhancement of N-methyl-d-aspartate receptor-mediated excitatory postsynaptic potentials in the neostriatum after methamphetamine sensitization. An in vitro slice study. Exp Brain Res 2002, 144:238-246.
31. Nagai T., Noda Y., Ishikawa K., Miyamoto Y., Yoshimura M., Ito M., Takayanagi M., Takuma K., Yamada K., Nabeshima T. The role of tissue plasminogen activator in methamphetamine-related reward and sensitization. J Neurochem 2005, 92:660-667.
32. Nagai T., Takuma K., Kamei H., Ito Y., Nakamichi N., Ibi D., Nakanishi Y., Murai M., Mizoguchi H., Nabeshima T., Yamada K. Dopamine D1 receptors regulate protein synthesis-dependent long-term recognition memory via extracellular signal-regulated kinase 1/2 in the prefrontal cortex. Learn Mem 2007, 14:117-125.
33. Nestler E.J. Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci 2001, 2:119-128.
34. Nordahl T.E., Salo R., Leamon M. Neuropsychological effects of chronic methamphetamine use on neurotransmitters and cognition: a review. J Neuropsychiatry Clin Neurosci 2003, 15:317-325.
35. Ohmori T., Abekawa T., Muraki A., Koyama T. Competitive and noncompetitive NMDA antagonists block sensitization to methamphetamine. Pharmacol Biochem Behav 1994, 48:587-591.
36. Raudensky J., Yamamoto B.K. Effects of chronic unpredictable stress and methamphetamine on hippocampal glutamate function. Brain Res 2007, 1135:129-135.
37. Rolls E.T., Kesner R.P. A computational theory of hippocampal function, and empirical tests of the theory. Prog Neurobiol 2006, 79:1-48.
38. Schroder N., O'Dell S.J., Marshall J.F. Neurotoxic methamphetamine regimen severely impairs recognition memory in rats. Synapse 2003, 49:89-96.
39. Sehatpour P., Molholm S., Schwartz T.H., Mahoney J.R., Mehta A.D., Javitt D.C., Stanton P.K., Foxe J.J. A human intracranial study of long-range oscillatory coherence across a frontal-occipital-hippocampal brain network during visual object processing. Proc Natl Acad Sci U S A 2008, 105:4399-4404.
40. Shoblock J.R., Sullivan E.B., Maisonneuve I.M., Glick S.D. Neurochemical and behavioral differences between d-methamphetamine and d-amphetamine in rats. Psychopharmacology (Berl) 2003, 165:359-369.
41. Simon S.L., Dacey J., Glynn S., Rawson R., Ling W. The effect of relapse on cognition in abstinent methamphetamine abusers. J Subst Abuse Treat 2004, 27:59-66.
42. Srisurapanont M., Ali R., Marsden J., Sunga A., Wada K., Monteiro M. Psychotic symptoms in methamphetamine psychotic in-patients. Int J Neuropsychopharmacol 2003, 6:347-352.
43. Steketee J.D. Neurotransmitter systems of the medial prefrontal cortex: potential role in sensitization to psychostimulants. Brain Res Brain Res Rev 2003, 41:203-228.
44. Stewart J., Druhan J.P. Development of both conditioning and sensitization of the behavioral activating effects of amphetamine is blocked by the non-competitive NMDA receptor antagonist, MK-801. Psychopharmacology (Berl) 1993, 110:125-132.
45. Ujike H. Advanced findings on the molecular mechanisms for behavioral sensitization to psychostimulants. Nippon Yakurigaku Zasshi 2001, 117:5-12.
46. Vorhees C.V., Williams M.T. Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat Protoc 2006, 1:848-858.
47. Wang H., Ferguson G.D., Pineda V.V., Cundiff P.E., Storm D.R. Overexpression of type-1 adenylyl cyclase in mouse forebrain enhances recognition memory and LTP. Nat Neurosci 2004, 7:635-642.
48. Weihmuller F.B., O'Dell S.J., Marshall J.F. MK-801 protection against methamphetamine-induced striatal dopamine terminal injury is associated with attenuated dopamine overflow. Synapse 1992, 11:155-163.
49. Wolf M.E., Jeziorski M. Coadministration of MK-801 with amphetamine, cocaine or morphine prevents rather than transiently masks the development of behavioral sensitization. Brain Res 1993, 613:291-294.
50. Yamada K., Noda Y., Hasegawa T., Komori Y., Nikai T., Sugihara H., Nabeshima T. The role of nitric oxide in dizocilpine-induced impairment of spontaneous alternation behavior in mice. J Pharmacol Exp Ther 1996, 276:460-466.
51. Yeh G.C., Chen J.C., Tsai H.C., Wu H.H., Lin C.Y., Hsu P.C., Peng Y.C. Amphetamine inhibits the N-methyl-d-aspartate receptor-mediated responses by directly interacting with the receptor/channel complex. J Pharmacol Exp Ther 2002, 300:1008-1016.
52. Yui K., Ikemoto S., Goto K., Nishijima K., Yoshino T., Ishiguro T. Spontaneous recurrence of methamphetamine-induced paranoid-hallucinatory states in female subjects: susceptibility to psychotic states and implications for relapse of schizophrenia. Pharmacopsychiatry 2002, 35:62-71.